Entos Pharmaceuticals Partners with Alberta Cell Therapy Manufacturing and the Ottawa Hospital Research Institute to Manufacture and Ready its COVID-19 DNA Vaccine for Clinical Trials
in the . Entos announces partnership with The Ottawa Hospital's Biotherapeutics Manufacturing Centre (BMC) to fill Covigenix VAX-001 in vials. BMC and ACTM will collaborate to boost Canada's biotherapeutics manufacturing capacity. EDMONTON, AB, Feb. 25, 2021 /CNW/ - Entos Pharmaceuticals (Entos), a biotechnology company developing genetic medicines with its Fusogenix nucleic acid delivery platform, is excited to work with Alberta Cell Therapy Manufacturing and The Ottawa Hospital's Biotherapeutics Manufacturing Centre to manufacture and ready doses of Entos' made-in-Canada Covigenix VAX-0...
Source: newswire.ca